Sharon Micallef's Publications

About Sharon Micallef's Publications

Senior Project Manager
  • RN,
  • BN,
  • Critical Care Cert

  • Serum chloride concentration and outcomes in adults receiving intravenous fluid therapy with a balanced crystalloid solution or 0.9% sodium chloride

    Intensive Care Medicine Date published:

  • Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis

    The Lancet Respiratory Medicine Date published:

  • Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia - a post hoc evaluation of the COVID STEROID 2 trial

    The Lancet Regional Health - Southeast Asia Date published:

  • Selective digestive tract decontamination in critically ill adults with acute brain injuries: a post hoc analysis of a randomized clinical trial

    Intensive Care Medicine Date published:

  • The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury

    Intensive Care Medicine Date published:

  • Heterogeneity of treatment effect of higher dose dexamethasone by geographic region in patients with COVID-19 and severe hypoxemia - Apost hocevaluation of the COVID STEROID 2 trial

    Unknown Date published:

  • Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation

    JAMA Date published:

  • Protocol for balanced versus saline trialists: living systematic review and individual patient data meta-analysis of randomised controlled trials (BEST-Living study)

    Critical Care and Resuscitation Date published:

  • Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

    Intensive Care Medicine Date published:

  • Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults

    New England Journal of Medicine Date published:

  • Balanced Crystalloids versus Saline in Critically Ill Adults - A Systematic Review with Meta-Analysis

    NEJM Evidence Date published:

  • Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

    Intensive Care Medicine Date published:

  • Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia

    JAMA Date published:

  • Balanced crystalloids compared to normal saline for fluid therapy in critically ill adult patients: Systematic review and meta-analysis protocol

    Unknown Date published:

  • Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan

    Acta Anaesthesiologica Scandinavica Date published:

  • The Plasma-Lyte 148 versus Saline (PLUS) statistical analysis plan: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality

    Critical Care and Resuscitation Date published: